tiprankstipranks
Numinus Wellness (TSE:NUMI)
TSX:NUMI

Numinus Wellness (NUMI) Stock Price & Analysis

179 Followers

NUMI Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.10 - C$0.31
Previous CloseC$0.13
Volume662.95K
Average Volume (3M)329.89K
Market Cap
C$34.60M
Enterprise ValueC$29.29M
Total Cash (Recent Filing)C$12.96M
Total Debt (Recent Filing)C$7.65M
Price to Earnings (P/E)-1.1
Beta2.15
Jan 17, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding267,083,600
10 Day Avg. Volume330,859
30 Day Avg. Volume329,894
Standard Deviation0.25
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.80
Price to Sales (P/S)5.75
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Ownership Overview

0.00% Mutual Funds
1.50% Other Institutional Investors
90.47% Public Companies and
Individual Investors

NUMI FAQ

What was Numinus Wellness’s price range in the past 12 months?
Numinus Wellness lowest stock price was C$0.10 and its highest was C$0.31 in the past 12 months.
    What is Numinus Wellness’s market cap?
    Currently, no data Available
    When is Numinus Wellness’s upcoming earnings report date?
    Numinus Wellness’s upcoming earnings report date is Jan 17, 2024 which is in 42 days.
      How were Numinus Wellness’s earnings last quarter?
      Numinus Wellness released its earnings results on Nov 29, 2023. The company reported -C$0.04 earnings per share for the quarter, missing the consensus estimate of -C$0.02 by -C$0.02.
        Is Numinus Wellness overvalued?
        According to Wall Street analysts Numinus Wellness’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Numinus Wellness pay dividends?
          Numinus Wellness does not currently pay dividends.
          What is Numinus Wellness’s EPS estimate?
          Numinus Wellness’s EPS estimate is -C$0.02.
            How many shares outstanding does Numinus Wellness have?
            Numinus Wellness has 266,181,730 shares outstanding.
              What happened to Numinus Wellness’s price movement after its last earnings report?
              Numinus Wellness reported an EPS of -C$0.04 in its last earnings report, missing expectations of -C$0.02. Following the earnings report the stock price went up 30%.
                Which hedge fund is a major shareholder of Numinus Wellness?
                Currently, no hedge funds are holding shares in TSE:NUMI

                ---

                Numinus Wellness Stock Smart Score

                Company Description

                Numinus Wellness

                Numinus Wellness Inc is engaged in the business of providing integrated health services. It provides health related therapies and respective research and development; analytics, testing and research of various controlled substances. The company's revenue is derived principally from the administration of traditional therapy services, provided by practitioners in its clinic.

                ---

                Top 5 ETFs holding NUMI

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold NUMI. The ETFs are listed according to market value of NUMI within the ETF

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Mind Medicine
                Revive Therapeutics
                Mydecine Innovations Group
                Tryp Therapeutics Inc

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis